FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor)

FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

United States ,China ,Japan ,Canada ,Mike Raab ,Kevin Martin ,Fosun Pharma ,Linkedin ,Exchange Commission On ,Renal Drugs Advisory Committee ,Drug Administration ,Ardelyx Inc ,Division Of Cardiology ,Advisory Committee ,Nasdaq ,Exchange Commission ,Prnewswire Ardelyx Inc ,Office Of New Drugs ,Division Of Nephrology At St ,Facebook ,Louis University ,New Drugs ,Drug Evaluation ,Complete Response Letter ,New Drug Application ,Internal Medicine ,Kyowa Kirin ,Knight Therapeutics ,Private Securities Reform Act ,Quarterly Report ,Resume ,Careers ,Da Grants Appeal For Ardelyx 39s Xphozah Tenapanor ,Iospace ,Advice ,